Remedy Shareholders Reelect Cho Bong-ho as Inside Director
Remedy said shareholders approved the reappointment of incumbent CEO Cho Bong-ho as an inside director at an extraordinary general meeting on Oct. 27, 2026.
Related stories
Doosan Enerbility Wins U.S. SMR Component Order
M impact | EQUITY | Oct 30, 2026, 12:18 AM UTC
Bambusa Therapeutics Prices Upsized IPO
M impact | EQUITY | Oct 30, 2026, 12:16 AM UTC
Nikkei Falls 1.3% as Electronics and Metals Stocks Lead Declines
Japanese stocks are lower ahead of the Bank of Japan’s rate decision and after Alphabet shares sold off overnight. Advantest is down 5.3% and JX Advanced Metals is 4.0% lower.
M impact | EQUITY | Oct 30, 2026, 12:15 AM UTC
Toggle Holdings Opens Below Its IPO Price
L impact | EQUITY | Oct 30, 2026, 12:14 AM UTC
ICE Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Oct 30, 2026, 12:14 AM UTC
Spectur Reports Q1 FY27 Revenue of A$1.47 Million
Q1 FY27 revenue included A$1.22 million in recurring revenue.
M impact | EQUITY | Oct 30, 2026, 12:12 AM UTC